ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Activity

15 hedge funds and large institutions have $2.16M invested in Enlivex Therapeutics in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$104K
2
Citadel Advisors
Citadel Advisors
Florida
+$19K
3
UBS Group
UBS Group
Switzerland
+$10K
4
WS
Wedbush Securities
California
+$6.86K
5
AIM
Acrospire Investment Management
Illinois
+$1.13K

Top Sellers

1
SM
Sabby Management
Florida
-$79.9K
2
OC
Oppenheimer & Co
New York
-$15.2K
3
HighTower Advisors
HighTower Advisors
Illinois
-$3.87K
4
BFA
BlackRock Fund Advisors
California
-$349
Name Holding Trade Value Shares
Change 		Shares
Change %
SM
1
Sabby Management
Florida
$1.36M -$79.9K -1,155 -6%
KCM
2
Knoll Capital Management
Florida
$424K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$146K +$104K +1,505 +250%
OC
4
Oppenheimer & Co
New York
$73K -$15.2K -222 -17%
HighTower Advisors
5
HighTower Advisors
Illinois
$59K -$3.87K -55 -6%
WS
6
Wedbush Securities
California
$36K +$6.86K +100 +24%
BFA
7
BlackRock Fund Advisors
California
$29K -$349 -5 -1%
Citadel Advisors
8
Citadel Advisors
Florida
$19K +$19K +279 New
UBS Group
9
UBS Group
Switzerland
$10K +$10K +138 New
AIM
10
Acrospire Investment Management
Illinois
$3K +$1.13K +15 +60%
BIM
11
BlackRock Investment Management
Delaware
$2K – – –
LTFS
12
Ladenburg Thalmann Financial Services
Florida
$2K – – –
Morgan Stanley
13
Morgan Stanley
New York
$1K – – –
VAM
14
Visium Asset Management
New York
– -$81K -1,271 Closed